NCT02745353View on ClinicalTrials.gov

Naloxegol in Cancer Opioid-Induced Constipation

PHASE2TerminatedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 22, 2017

Study Completion Date

June 22, 2017

Conditions

Constipation

Interventions

DRUG

naloxegol

Trial Locations (1)

92093

UCSD Moores Cancer Center, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Joseph Ma

OTHER